397030.KS · 에이프릴바이오
South Korea · RS rating 2 · As of 2026-10-14
| Price | 13,010.00 KRW |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 4 / 2 / 12 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 17 / 30 |
| Industry group (rank) | Medical-Biomed/Biotech (95) |
| EPS growth Q/Q | -1044.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +82.2% |
| Market cap (USD) | $253.9M |